FLUCELVAX QUAD (Seqirus Pty Ltd)
Product name
FLUCELVAX QUAD
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
198 working days (255)
Active ingredients
influenza virus haemagglutinin
Registration type
NCE/NBE
Indication
FLUCELVAX QUAD (suspension for injection) is indicated for the prevention of influenza caused by Influenza Virus, Types A and B contained in the vaccine. The vaccine is indicated for use in adults and children 9 years of age and older.
For full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.